Huntington National Bank’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $239K | Buy |
3,544
+883
| +33% | +$58.8K | ﹤0.01% | 858 |
|
|
2026
Q1 | $167K | Buy |
2,661
+314
| +13% | +$21.9K | ﹤0.01% | 908 |
|
|
2025
Q4 | $156K | Sell |
2,347
-426
| -15% | -$27.5K | ﹤0.01% | 825 |
|
|
2025
Q3 | $187K | Buy |
2,773
+292
| +12% | +$23.1K | ﹤0.01% | 782 |
|
|
2025
Q2 | $217K | Hold |
2,481
| – | – | ﹤0.01% | 722 |
|
|
2025
Q1 | $169K | Sell |
2,481
-267
| -10% | -$21.8K | ﹤0.01% | 755 |
|
|
2024
Q4 | $214K | Buy |
2,748
+1,335
| +94% | +$98.8K | ﹤0.01% | 711 |
|
|
2024
Q3 | $94.7K | Sell |
1,413
-200
| -12% | -$16.4K | ﹤0.01% | 930 |
|
|
2024
Q2 | $183K | Sell |
1,613
-1,620
| -50% | -$205K | ﹤0.01% | 714 |
|
|
2024
Q1 | $448K | Buy |
3,233
+2,222
| +220% | +$279K | ﹤0.01% | 509 |
|
|
2023
Q4 | $125K | Sell |
1,011
-158
| -14% | -$16.1K | ﹤0.01% | 785 |
|
|
2023
Q3 | $109K | Buy |
1,169
+17
| +1% | +$1.92K | ﹤0.01% | 801 |
|
|
2023
Q2 | $148K | Buy |
1,152
+499
| +76% | +$60.4K | ﹤0.01% | 736 |
|
|
2023
Q1 | $75.9K | Buy |
653
+61
| +10% | +$6.83K | ﹤0.01% | 872 |
|
|
2022
Q4 | $67K | Buy |
592
+144
| +32% | +$15.8K | ﹤0.01% | 900 |
|
|
2022
Q3 | $36K | Sell |
448
-97
| -18% | -$8.21K | ﹤0.01% | 1088 |
|
|
2022
Q2 | $41K | Sell |
545
-763
| -58% | -$69.6K | ﹤0.01% | 1060 |
|
|
2022
Q1 | $168K | Buy |
1,308
+216
| +20% | +$23.6K | ﹤0.01% | 685 |
|
|
2021
Q4 | $146K | Buy |
1,092
+912
| +507% | +$131K | ﹤0.01% | 736 |
|
|
2021
Q3 | $25K | Sell |
180
-2,500
| -93% | -$315K | ﹤0.01% | 1164 |
|
|
2021
Q2 | $286K | Buy |
2,680
+2,520
| +1,575% | +$242K | ﹤0.01% | 554 |
|
|
2021
Q1 | $14K | Sell |
160
-44
| -22% | -$4.13K | ﹤0.01% | 1251 |
|
|
2020
Q4 | $19K | Buy |
204
+12
| +6% | +$1.07K | ﹤0.01% | 1137 |
|
|
2020
Q3 | $19K | Buy |
192
+32
| +20% | +$3.34K | ﹤0.01% | 1063 |
|
|
2020
Q2 | $16K | Sell |
160
-944
| -86% | -$84.4K | ﹤0.01% | 1105 |
|
|
2020
Q1 | $75K | Sell |
1,104
-14,436
| -93% | -$898K | ﹤0.01% | 671 |
|
|
2019
Q4 | $850K | Buy |
15,540
+864
| +6% | +$41K | 0.01% | 333 |
|
|
2019
Q3 | $548K | Buy |
14,676
+14,516
| +9,073% | +$564K | 0.01% | 379 |
|
|
2019
Q2 | $6K | Hold |
160
| – | – | ﹤0.01% | 1375 |
|
|
2019
Q1 | $5K | Hold |
160
| – | – | ﹤0.01% | 1381 |
|
|
2018
Q4 | $5K | Hold |
160
| – | – | ﹤0.01% | 1429 |
|
|
2018
Q3 | $6K | Hold |
160
| – | – | ﹤0.01% | 1469 |
|
|
2018
Q2 | $4K | Buy |
+160
| New | +$3.39K | ﹤0.01% | 1466 |
|
|
2016
Q4 | – | Sell |
-1,044
| Closed | -$23K | – | 1453 |
|
|
2016
Q3 | $23K | Hold |
1,044
| – | – | ﹤0.01% | 1101 |
|
|
2016
Q2 | $21K | Sell |
1,044
-3,552
| -77% | -$60.5K | ﹤0.01% | 1114 |
|
|
2016
Q1 | $72K | Buy |
4,596
+2,416
| +111% | +$40.4K | ﹤0.01% | 1003 |
|
|
2015
Q4 | $45K | Sell |
2,180
-140
| -6% | -$2.91K | ﹤0.01% | 1047 |
|
|
2015
Q3 | $50K | Buy |
2,320
+244
| +12% | +$5.44K | ﹤0.01% | 1048 |
|
|
2015
Q2 | $42K | Sell |
2,076
-2,520
| -55% | -$44.3K | ﹤0.01% | 1153 |
|
|
2015
Q1 | $72K | Buy |
4,596
+364
| +9% | +$5.5K | ﹤0.01% | 1007 |
|
|
2014
Q4 | $58K | Buy |
+4,232
| New | +$51.8K | ﹤0.01% | 1076 |
|
|
2014
Q1 | – | Sell |
-4,000
| Closed | -$35K | – | 1270 |
|
|
2013
Q4 | $35K | Buy |
4,000
+2,000
| +100% | +$15.8K | ﹤0.01% | 1194 |
|
|
2013
Q3 | $14K | Hold |
2,000
| – | – | ﹤0.01% | 1399 |
|
|
2013
Q2 | $11K | Buy |
+2,000
| New | +$9.58K | ﹤0.01% | 1411 |
|
Other funds holding DXCM
Huntington National Bank's DXCM Position: Q2 2026 in Review
Huntington National Bank increased its DexCom (DXCM) stake by 33% in Q2 2026, buying an estimated $58.8K and bringing the position to 3,544 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #858.
Huntington National Bank first reported a position in DXCM in Q2 2013 and has held it in 44 quarters since. The position peaked at $850K in Q4 2019. 977 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Huntington National Bank held 3,544 shares of DexCom worth $239K as of Q2 2026.
- Huntington National Bank bought 883 DexCom shares in Q2 2026, an estimated $58.8K.
- DexCom made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #858 holding.
- Huntington National Bank first reported a position in DexCom in Q2 2013 and has held it in 44 quarters since.
- Huntington National Bank's DexCom position peaked at $850K in Q4 2019.
- 977 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.